{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:51:16Z","timestamp":1789203076545,"version":"build-2803163510"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcBITAK","doi-asserted-by":"crossref","award":["SBAG 118S443"],"award-info":[{"award-number":["SBAG 118S443"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcBITAK","doi-asserted-by":"crossref","award":["SBAG 119S769"],"award-info":[{"award-number":["SBAG 119S769"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017618","name":"Division of Diabetes, Endocrinology, and Metabolic Diseases","doi-asserted-by":"publisher","award":["R01-DK110567"],"award-info":[{"award-number":["R01-DK110567"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Mi 294\/10-1"],"award-info":[{"award-number":["Mi 294\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dysfunction of the lower urinary tract (LUT) including urinary bladder and urethra (and prostate in men) is one of the most frequent complications of diabetes and can manifest as overactive bladder, underactive bladder, urinary incontinence, and as aggravated symptoms of benign prostate hyperplasia. We have performed a selective literature search to review existing evidence on efficacy of classic medications for the treatment of LUT dysfunction in diabetic patients and animals, i.e., \u03b1<jats:sub>1<\/jats:sub>-adrenoceptor and\u00a0muscarinic receptor antagonists, \u03b2<jats:sub>3<\/jats:sub>-adrenoceptor agonists, and phosphodiesterase type 5 inhibitors. Generally, these agents appear to have comparable efficacy in patients and\/or animals with and without diabetes. We also review effects of antidiabetic medications on LUT function. Such studies have largely been performed in animal models. In the streptozotocin-induced models of type 1 diabetes, insulin can prevent and reverse alterations of morphology, function, and gene expression patterns in bladder and prostate. Typical medications for the treatment of type 2 diabetes have been studied less often, and the reported findings are not yet sufficient to derive robust conclusions. Thereafter, we review animal studies with emerging medications perhaps targeting diabetes-associated LUT dysfunction. Data with myoinositol, daidzein, and with compounds that target oxidative stress, inflammation, Rac1, nerve growth factor, angiotensin II receptor, serotonin receptor, adenosine receptor, and soluble guanylyl cyclase are not conclusive yet, but some hold promise as potential treatments. Finally, we review nonpharmacological interventions in diabetic bladder dysfunction. These approaches are relatively new and give promising results in preclinical studies. In conclusion, the insulin data in rodent models of type 1 diabetes suggest that diabetes-associated LUT function can be mostly or partially reversed. However, we propose that considerable additional experimental and clinical studies are needed to target diabetes itself or pathophysiological changes induced by chronic hyperglycemia for the treatment of diabetic uropathy.<\/jats:p>","DOI":"10.1007\/s00210-022-02249-9","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T01:02:37Z","timestamp":1652317357000},"page":"887-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Established and emerging treatments for diabetes-associated lower urinary tract dysfunction"],"prefix":"10.1007","volume":"395","author":[{"given":"Bet\u00fcl R.","family":"Erdogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Arioglu-Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-8467","authenticated-orcid":false,"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"2249_CR1","doi-asserted-by":"publisher","unstructured":"Alshehri MM, Sharifi-Rad J, Herrera-Bravo J, Jara EL, Salazar LA, Kregiel D, Uprety Y, Akram M, Iqbal M, Martorell M (2021) Therapeutic potential of isoflavones with an emphasis on daidzein. Oxidative Med Cell Longev\u00a02021:6331630. https:\/\/doi.org\/10.1155\/2021\/6331630","DOI":"10.1155\/2021\/6331630"},{"key":"2249_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2017.01.170","volume":"88","author":"PJ Antony","year":"2017","unstructured":"Antony PJ, Gandhi GR, Stalin A, Balakrishna K, Toppo E, Sivasankaran K, Ignacimuthu S, Al-Dhabi NA (2017) Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Biomed Pharmacother 88:1098\u20131113. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.170","journal-title":"Biomed Pharmacother"},{"key":"2249_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.urology.2018.09.004","volume":"123","author":"T Antunes-Lopes","year":"2019","unstructured":"Antunes-Lopes T, Vasconcelos A, Costa D, Charrua A, Neves J, Silva J, Cruz F, Silva C (2019) The impact of chronic pelvic ischemia on LUTS and urinary levels of neuroinflammatory, inflammatory, and oxidative stress markers in elderly men: a case-control study. Urology 123:230\u2013234. https:\/\/doi.org\/10.1016\/j.urology.2018.09.004","journal-title":"Urology"},{"key":"2249_CR4","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/nau.23490","volume":"37","author":"E Arioglu Inan","year":"2018","unstructured":"Arioglu Inan E, Ellenbroek JH, Michel MC (2018) A systematic review of urinary bladder hypertrophy in experimental diabetes: part I. streptozotocin-induced rat models. Neurourol Urodyn 37:1212\u20131219. https:\/\/doi.org\/10.1002\/nau.23490","journal-title":"Neurourol Urodyn"},{"key":"2249_CR5","unstructured":"Arioglu Inan E, Bese OD, Karaca GE, San HS, Kayki Mutlu G, Erdogan BR, Michel MC (2022) The angiotensin II receptor antagonist valsartan does not attenuate diabetes-induced bladder enlargement in rats. Neurourol Urodyn Press"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.prnil.2017.02.004","volume":"5","author":"HA Atalay","year":"2017","unstructured":"Atalay HA, Akarsu M, Canat L, \u00dclker V, Alkan \u0130, Ozkuvanc\u0131 U (2017) Impact of poor glycemic control of type 2 diabetes mellitus on serum prostate-specific antigen concentrations in men. Prostate Int 5:104\u2013109. https:\/\/doi.org\/10.1016\/j.prnil.2017.02.004","journal-title":"Prostate Int"},{"key":"2249_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","volume":"154","author":"MJ Barry","year":"1995","unstructured":"Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, Lepor H (1995) Benign prostatic hyperplasia specific healthy status measures in clinical research: how much change in the American Urological Association Symptom Index and the Benign Prostatic Hyerplasia Impact Index is perceptible to patients? J Urol 154:1770\u20131774. https:\/\/doi.org\/10.1016\/S0022-5347(01)66780-6","journal-title":"J Urol"},{"key":"2249_CR8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/circresaha.115.306884","volume":"118","author":"JA Beckman","year":"2016","unstructured":"Beckman JA, Creager MA (2016) Vascular complications of diabetes. Circ Res 118:1771\u20131785. https:\/\/doi.org\/10.1161\/circresaha.115.306884","journal-title":"Circ Res"},{"key":"2249_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.22037\/uj.v0i0.5504","volume":"17","author":"MS Boga","year":"2020","unstructured":"Boga MS, Halilo\u011flu AH, G\u00fclp\u0131nar \u00d6, \u00d6zayar A, S\u00f6nmez MG, Pinarli FA, Bo\u011fa E, Pinarci T, Tiryaki M, G\u00f6\u011f\u00fc\u015f O (2020) Neonatal bladder-derived mesenchymal stem cells ameliorate bladder dysfunction in diabetic rat models. Urol J 17:413\u2013421. https:\/\/doi.org\/10.22037\/uj.v0i0.5504","journal-title":"Urol J"},{"key":"2249_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/00365590410015678","volume":"38","author":"M Bozlu","year":"2004","unstructured":"Bozlu M, Ulusoy E, Cayan S, Akbay E, G\u00f6r\u00fcr S, Akbay E (2004) A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scand J Urol Nephrol 38:391\u2013395. https:\/\/doi.org\/10.1080\/00365590410015678","journal-title":"Scand J Urol Nephrol"},{"key":"2249_CR11","doi-asserted-by":"publisher","first-page":"666334","DOI":"10.3389\/fphar.2021.666334","volume":"12","author":"KJ Bubb","year":"2021","unstructured":"Bubb KJ, Ravindran D, Cartland SP, Finemore M, Clayton ZE, Tsang M, Tang O, Kavurma MM, Patel S, Figtree GA (2021) \u03b23-Adrenergic receptor stimulation promotes reperfusion in ischemic limbs in a murine diabetic model. Front Pharmacol 12:666334. https:\/\/doi.org\/10.3389\/fphar.2021.666334","journal-title":"Front Pharmacol"},{"key":"2249_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.ju.0000141583.31183.7a","volume":"173","author":"AK Changolkar","year":"2005","unstructured":"Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ, Chacko S (2005) Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 173:309\u2013313. https:\/\/doi.org\/10.1097\/01.ju.0000141583.31183.7a","journal-title":"J Urol"},{"key":"2249_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/nau.22280","volume":"32","author":"SC Chen","year":"2013","unstructured":"Chen SC, Lai CH, Fan WJ, Peng CW (2013) Pudendal neuromodulation improves voiding efficiency in diabetic rats. Neurourol Urodyn 32:293\u2013300. https:\/\/doi.org\/10.1002\/nau.22280","journal-title":"Neurourol Urodyn"},{"key":"2249_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000355711","volume":"93","author":"S Chen","year":"2014","unstructured":"Chen S, Zhu Y, Feng X, Zhang Z, Li S, Shi B (2014) Changes in alpha1-adrenoceptor and NGF\/proNGF pathway: a possible mechanism in diabetic urethral dysfunction. Urol Int 93:344\u2013351. https:\/\/doi.org\/10.1159\/000355711","journal-title":"Urol Int"},{"key":"2249_CR15","doi-asserted-by":"publisher","first-page":"e0126457","DOI":"10.1371\/journal.pone.0126457","volume":"10","author":"S Chen","year":"2015","unstructured":"Chen S, Zhu Y, Liu Z, Gao Z, Li B, Zhang D, Zhang Z, Jiang X, Liu Z, Meng L, Yang Y, Shi B (2015) Grape seed proanthocyanidin extract ameliorates diabetic bladder dysfunction via the activation of the Nrf2 pathway. PLoS ONE 10:e0126457. https:\/\/doi.org\/10.1371\/journal.pone.0126457","journal-title":"PLoS ONE"},{"key":"2249_CR16","doi-asserted-by":"publisher","first-page":"F838","DOI":"10.1152\/ajprenal.00625.2020","volume":"320","author":"L Chen","year":"2021","unstructured":"Chen L, Lv L, Zhang L, Gao Z, Liu Y, Wang S, Zhou N, Xia Y, Cui J, Jiang X, Zhang X, Li Y, Shi B (2021) Metformin ameliorates bladder dysfunction in a rat model of partial bladder outlet obstruction. Am J Physiol Renal Physiol 320:F838-f858. https:\/\/doi.org\/10.1152\/ajprenal.00625.2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"2249_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neulet.2008.06.008","volume":"441","author":"JT Cheng","year":"2008","unstructured":"Cheng JT, Tong YC (2008) Alterations of nerve-growth factor and p75 NTR expression in urinary bladder of fructose-fed obese rats. Neurosci Lett 441:25\u201328. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.008","journal-title":"Neurosci Lett"},{"key":"2249_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jnutbio.2013.09.012","volume":"25","author":"SH Cheong","year":"2014","unstructured":"Cheong SH, Furuhashi K, Ito K, Nagaoka M, Yonezawa T, Miura Y, Yagasaki K (2014) Daidzein promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and improves glucose homeostasis in Type 2 diabetic model mice. J Nutr Biochem 25:136\u2013143","journal-title":"J Nutr Biochem"},{"key":"2249_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jnutbio.2009.06.012","volume":"21","author":"KW Cho","year":"2010","unstructured":"Cho KW, Lee O-H, Banz WJ, Moustaid-Moussa N, Shay NF, Kim Y-C (2010) Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPAR\u03b3 transcriptional activity. J Nutr Biochem 21:841\u2013847","journal-title":"J Nutr Biochem"},{"key":"2249_CR20","doi-asserted-by":"publisher","first-page":"1163e1111","DOI":"10.1016\/j.urology.2012.05.002","volume":"80","author":"ST Cho","year":"2012","unstructured":"Cho ST, Park EY, Kim JC (2012) Effect of angiotensin II receptor antagonist telmisartan on detrusor overactivity in rats with bladder outlet obstruction. Urology 80:1163e1111-1163e1167. https:\/\/doi.org\/10.1016\/j.urology.2012.05.002","journal-title":"Urology"},{"key":"2249_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/dmrr.780","volume":"24","author":"M Choi","year":"2008","unstructured":"Choi M, Jung U, Yeo J, Kim M, Lee M (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24:74\u201381","journal-title":"Diabetes Metab Res Rev"},{"key":"2249_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5213\/inj.1834982.491","volume":"22","author":"H Choi","year":"2018","unstructured":"Choi H, Bae JH, Oh CY, Jeong SJ, Ko WJ, Choi JB, Seo JT, Lee DH, Kim JC, Lee KW, Kim YH (2018) Clnical efficacy of solifenacin in the management of diabetes mellitus-associated versus idiopathic overactive bladder symptoms: a multicenter prospective study. Int Neurourol J 22:51\u201357. https:\/\/doi.org\/10.5213\/inj.1834982.491","journal-title":"Int Neurourol J"},{"key":"2249_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1464-410X.2006.06058.x","volume":"97","author":"GJ Christ","year":"2006","unstructured":"Christ GJ, Hsieh Y, Zhao W, Schenk G, Venkateswarlu K, Wang HZ, Tar MT, Melman A (2006) Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int 97:1076\u20131082. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06058.x","journal-title":"BJU Int"},{"key":"2249_CR24","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","volume":"95","author":"ML Croze","year":"2013","unstructured":"Croze ML, Soulage CO (2013) Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95:1811\u20131827. https:\/\/doi.org\/10.1016\/j.biochi.2013.05.011","journal-title":"Biochimie"},{"key":"2249_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","volume":"21","author":"AM Cypess","year":"2015","unstructured":"Cypess AM, Weiner LS, Roberts-Toler C, Franquet E, Kessler SH, Kahn PA, English J, Chatman K, Trauger SA, Doria A, Kolodny GM (2015) Activation of human brown adipose tissue by a \u00df3-adrenergic receptor agonist. Cell Metab 21:33\u201338. https:\/\/doi.org\/10.1016\/j.cmet.2014.12.009","journal-title":"Cell Metab"},{"key":"2249_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.semnephrol.2005.09.009","volume":"26","author":"F Daneshgari","year":"2006","unstructured":"Daneshgari F, Moore C (2006) Diabetic uropathy. Semin Nephrol 26:182\u2013185. https:\/\/doi.org\/10.1016\/j.semnephrol.2005.09.009","journal-title":"Semin Nephrol"},{"key":"2249_CR27","doi-asserted-by":"publisher","first-page":"R1728","DOI":"10.1152\/ajpregu.00654.2005","volume":"290","author":"F Daneshgari","year":"2006","unstructured":"Daneshgari F, Huang X, Liu G, Bena J, Saffore L, Powell CT (2006) Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol 290:R1728-1735. https:\/\/doi.org\/10.1152\/ajpregu.00654.2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2249_CR28","doi-asserted-by":"publisher","unstructured":"Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S (2009) Diabetic bladder dysfunction: current translational knowledge. J Urol 182 Suppl.: S18-S26. https:\/\/doi.org\/10.1016\/j.juro.2009.08.070","DOI":"10.1016\/j.juro.2009.08.070"},{"key":"2249_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5213\/inj.2040344.172","volume":"25","author":"F Dimitriadis","year":"2021","unstructured":"Dimitriadis F, Papaioannou M, Sokolakis I, Fragou A, Hatzichristou D, Apostolidis A (2021) The effect of low-intensity extracorporeal shockwave treatment on the urinary bladder in an experimental diabetic rat model. Int Neurourol J 25:34\u201341. https:\/\/doi.org\/10.5213\/inj.2040344.172","journal-title":"Int Neurourol J"},{"key":"2249_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ajhp\/61.2.160","volume":"61","author":"JJ Duby","year":"2004","unstructured":"Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA (2004) Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 61:160\u2013173","journal-title":"Am J Health Syst Pharm"},{"key":"2249_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.prnil.2016.07.005","volume":"4","author":"A Elabbady","year":"2016","unstructured":"Elabbady A, Hashad MM, Kotb AF, Ghanem AE (2016) Studying the effect of type 2 diabetes mellitus on prostate-related parameters: A prospective single institutional study. Prostate Int 4:156\u2013159. https:\/\/doi.org\/10.1016\/j.prnil.2016.07.005","journal-title":"Prostate Int"},{"key":"2249_CR32","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/nau.23786","volume":"37","author":"JH Ellenbroek","year":"2018","unstructured":"Ellenbroek JH, Arioglu Inan E, Michel MC (2018) A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences. Neurourol Urodyn 37:2346\u20132360. https:\/\/doi.org\/10.1002\/nau.23786","journal-title":"Neurourol Urodyn"},{"key":"2249_CR33","doi-asserted-by":"publisher","first-page":"104304","DOI":"10.1016\/j.yexmp.2019.104304","volume":"111","author":"RA Elrashidy","year":"2019","unstructured":"Elrashidy RA, Liu G (2019) Long-term diabetes causes molecular alterations related to fibrosis and apoptosis in rat urinary bladder. Exp Mol Pathol 111:104304. https:\/\/doi.org\/10.1016\/j.yexmp.2019.104304","journal-title":"Exp Mol Pathol"},{"key":"2249_CR34","doi-asserted-by":"publisher","first-page":"F906","DOI":"10.1152\/ajprenal.00221.2019","volume":"317","author":"RA Elrashidy","year":"2019","unstructured":"Elrashidy RA, Kavran M, Asker ME, Mohamed HE, Daneshgari F, Liu G (2019) Smooth muscle-specific deletion of MnSOD exacerbates diabetes-induced bladder dysfunction in mice. Am J Physiol Renal Physiol 317:F906\u2013F912. https:\/\/doi.org\/10.1152\/ajprenal.00221.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2249_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bcpt.12346","volume":"116","author":"AS Evcim","year":"2015","unstructured":"Evcim AS, Micili SC, Karaman M, Erbil G, Guneli E, Gidener S, Gumustekin M (2015) The role of Rac1 on carbachol-induced contractile activity in detrusor smooth muscle from streptozotocin-induced diabetic rats. Basic Clin Pharmacol Toxicol 116:476\u2013484. https:\/\/doi.org\/10.1111\/bcpt.12346","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2249_CR36","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/s0022-5347(17)36459-5","volume":"149","author":"Y Fukumoto","year":"1993","unstructured":"Fukumoto Y, Yoshida M, Dokita S, Kamai T, Weiss RM, Latifpour J (1993) The reversal effect of insulin on diabetes-induced alterations in beta adrenergic and muscarinic receptors in rat prostate. J Urol 149:1602\u20131606. https:\/\/doi.org\/10.1016\/s0022-5347(17)36459-5","journal-title":"J Urol"},{"key":"2249_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2337\/diab.43.6.819","volume":"43","author":"Y Fukumoto","year":"1994","unstructured":"Fukumoto Y, Yoshida M, Weiss RM, Latifpour J (1994) Reversability of diabetes- and diuresis-induced alterations in rat bladder dome muscarinic receptors. Diabetes 43:819\u2013826. https:\/\/doi.org\/10.2337\/diab.43.6.819","journal-title":"Diabetes"},{"key":"2249_CR38","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S0022-5347(05)66407-5","volume":"165","author":"WF Goins","year":"2001","unstructured":"Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, Bennett N Jr, De Groat WC, Glorioso JC, Chancellor MB (2001) Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol 165:1748\u20131754. https:\/\/doi.org\/10.1016\/S0022-5347(05)66407-5","journal-title":"J Urol"},{"key":"2249_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/nau.23372","volume":"37","author":"D Gotoh","year":"2018","unstructured":"Gotoh D, Torimoto K, Tatsumi Y, Hori S, Yamada A, Miyake M, Morizawa Y, Aoki K, Tanaka N, Hirayama A, Fujimoto K (2018) Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats. Neurourol Urodyn 37:666\u2013672. https:\/\/doi.org\/10.1002\/nau.23372","journal-title":"Neurourol Urodyn"},{"key":"2249_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/luts.12272","volume":"11","author":"D Gotoh","year":"2019","unstructured":"Gotoh D, Torimoto K, Iwasaki H, Iwamoto T, Morizawa Y, Hori S, Miyake M, Tanaka N, Hirayama A, Nishi E, Fujimoto K (2019) Tadalafil, a phosphodiesterase type 5 inhibitor, restores urethra and detrusor function in the initial phase of diabetes in rats. Low Urin Tract Symptoms 11:241\u2013247. https:\/\/doi.org\/10.1111\/luts.12272","journal-title":"Low Urin Tract Symptoms"},{"key":"2249_CR41","doi-asserted-by":"publisher","first-page":"120001","DOI":"10.1016\/j.lfs.2021.120001","volume":"286","author":"D Gotoh","year":"2021","unstructured":"Gotoh D, Cao N, Alexandre EC, Saito T, Morizawa Y, Hori S, Miyake M, Torimoto K, Fujimoto K, Yoshimura N (2021) Effects of low-dose insulin or a soluble guanylate cyclase activator on lower urinary tract dysfunction in streptozotocin-induced diabetic rats. Life Sci 286:120001. https:\/\/doi.org\/10.1016\/j.lfs.2021.120001","journal-title":"Life Sci"},{"key":"2249_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pros.2990190205","volume":"19","author":"A Gousse","year":"1991","unstructured":"Gousse A, Yoshida M, Weiss RM, Latifpour J (1991) Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol. Prostate 19:121\u2013131. https:\/\/doi.org\/10.1002\/pros.2990190205","journal-title":"Prostate"},{"key":"2249_CR43","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KA, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67:1099\u20131109. https:\/\/doi.org\/10.1016\/j.eururo.2014.12.038","journal-title":"Eur Urol"},{"key":"2249_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/nau.21182","volume":"31","author":"B Gu","year":"2012","unstructured":"Gu B, Wu G, Si J, Xu Y, Andersson KE (2012) Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist. Neurourol Urodyn 31:168\u2013173. https:\/\/doi.org\/10.1002\/nau.21182","journal-title":"Neurourol Urodyn"},{"key":"2249_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/nau.22334","volume":"32","author":"US Ha","year":"2013","unstructured":"Ha US, Bae WJ, Kim SJ, Yoon BI, Jang H, Hong SH, Lee JY, Hwang SY, Kim SW (2013) Protective effect of cyanidin-3-O-beta-D-glucopyranoside fraction from mulberry fruit pigment against oxidative damage in streptozotocin-induced diabetic rat bladder. Neurourol Urodyn 32:493\u2013499. https:\/\/doi.org\/10.1002\/nau.22334","journal-title":"Neurourol Urodyn"},{"key":"2249_CR46","doi-asserted-by":"publisher","first-page":"5558890","DOI":"10.1155\/2021\/5558890","volume":"2021","author":"X Han","year":"2021","unstructured":"Han X, Gao Y, Yin X, Wang S, Zhang X, Chen Q (2021) Effect of electroacupuncture on bladder dysfunction via regulation of MLC and MLCK phosphorylation in a rat model of type 2 diabetes mellitus. Evid Based Complement Alternat Med 2021:5558890. https:\/\/doi.org\/10.1155\/2021\/5558890","journal-title":"Evid Based Complement Alternat Med"},{"key":"2249_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW (2019) Global trends in diabetes complications: a review of current evidence. Diabetologia 62:3\u201316. https:\/\/doi.org\/10.1007\/s00125-018-4711-2","journal-title":"Diabetologia"},{"key":"2249_CR48","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4149\/neo_2016_405","volume":"63","author":"Y He","year":"2016","unstructured":"He Y, Wu X, Cao Y, Hou Y, Chen H, Wu L, Lu L, Zhu W, Gu Y (2016) Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway. Neoplasma 63:523\u2013531","journal-title":"Neoplasma"},{"key":"2249_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00345-009-0460-7","volume":"28","author":"K H\u00f6fner","year":"2010","unstructured":"H\u00f6fner K, Burkart M, Jacob G, Jonas U (2010) Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol 28:353\u2013357. https:\/\/doi.org\/10.1007\/s00345-009-0460-7","journal-title":"World J Urol"},{"key":"2249_CR50","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/nau.24449","volume":"39","author":"Y Hotta","year":"2020","unstructured":"Hotta Y, Takahashi S, Tokoro M, Naiki-Ito A, Maeda K, Kawata R, Kataoka T, Ohta Y, Hamakawa T, Takahashi S, Yasui T, Kimura K (2020) Anagliptin, a dipeptidyl peptidase-4 inhibitor, improved bladder function and hemodynamics in rats with bilateral internal iliac artery ligation. Neurourol Urodyn 39:1922\u20131929. https:\/\/doi.org\/10.1002\/nau.24449","journal-title":"Neurourol Urodyn"},{"key":"2249_CR51","doi-asserted-by":"publisher","first-page":"046001","DOI":"10.1088\/1741-2560\/13\/4\/046001","volume":"13","author":"TH Hsieh","year":"2016","unstructured":"Hsieh TH, Lin YT, Chen SC, Peng CW (2016) Chronic pudendal neuromodulation using an implantable microstimulator improves voiding function in diabetic rats. J Neural Eng 13:046001. https:\/\/doi.org\/10.1088\/1741-2560\/13\/4\/046001","journal-title":"J Neural Eng"},{"key":"2249_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13287-020-01795-4","volume":"11","author":"Y Huang","year":"2020","unstructured":"Huang Y, Gao J, Zhou Y, Wu S, Shao Y, Xue H, Shen B, Ding L, Wei Z (2020) Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model. Stem Cell Res Ther 11:278. https:\/\/doi.org\/10.1186\/s13287-020-01795-4","journal-title":"Stem Cell Res Ther"},{"key":"2249_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2337\/db18-0845","volume":"68","author":"FM Hughes Jr","year":"2019","unstructured":"Hughes FM Jr, Hirshman NA, Inouye BM, Jin H, Stanton EW, Yun CE, Davis LG, Routh JC, Purves JT (2019) NLRP3 promotes diabetic bladder dysfunction and changes in symptom-specific bladder innervation. Diabetes 68:430\u2013440. https:\/\/doi.org\/10.2337\/db18-0845","journal-title":"Diabetes"},{"key":"2249_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/toxins14010053","volume":"14","author":"H Ibrahim","year":"2022","unstructured":"Ibrahim H, Maignel J, Hornby F, Daly D, Beard M (2022) BoNT\/A in the urinary bladder\u2014more to the story than silencing of cholinergic nerves. Toxins 14:53","journal-title":"Toxins"},{"key":"2249_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(05)67491-5","volume":"164","author":"K Ikeda","year":"2000","unstructured":"Ikeda K, Wada Y, Foster HE Jr, Wang Z, Weiss RM, Latifpour J (2000) Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta. J Urol 164:180\u2013185","journal-title":"J Urol"},{"key":"2249_CR56","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reillly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u20131315. https:\/\/doi.org\/10.1016\/j.eururo.2006.09.019","journal-title":"Eur Urol"},{"key":"2249_CR57","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/jcp.29106","volume":"235","author":"GL Jia","year":"2020","unstructured":"Jia GL, Huang Q, Cao YN, Xie CS, Shen YJ, Chen JL, Lu JH, Zhang MB, Li J, Tao YX (2020) Cav-1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway. J Cell Physiol 235:2060\u20132070","journal-title":"J Cell Physiol"},{"key":"2249_CR58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1745-7254.2008.00790.x","volume":"29","author":"YJ Jiang","year":"2008","unstructured":"Jiang YJ, Gong DX, Liu HB, Yang CM, Sun ZX, Kong CZ (2008) Ability of \u03b1-lipoic acid to reverse the diabetic cystopathy in a rat model. Acta Pharmacol Sin 29:713\u2013719. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00790.x","journal-title":"Acta Pharmacol Sin"},{"key":"2249_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/luts.12155","volume":"10","author":"S Kageyama","year":"2018","unstructured":"Kageyama S, Beppu M, Ohnogi H, Miyazaki S, Haruno A, Ito Y, Yamada S (2018) Clinical effects of formulated food of peucedanum japonicum extract and saw palmetto extract in male patients with lower urinary tract symptoms. Low Urin Tract Symptoms 10:167\u2013174. https:\/\/doi.org\/10.1111\/luts.12155","journal-title":"Low Urin Tract Symptoms"},{"key":"2249_CR60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/s0022-5347(17)32646-0","volume":"152","author":"T Kamai","year":"1994","unstructured":"Kamai T, Fukumoto Y, Gousse A, Yoshida M, Davenport TA, Weiss RM, Latifpour J (1994) Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens. J Urol 152:1017\u20131021. https:\/\/doi.org\/10.1016\/s0022-5347(17)32646-0","journal-title":"J Urol"},{"key":"2249_CR61","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1464-410X.2010.09655.x","volume":"107","author":"ND Kanika","year":"2011","unstructured":"Kanika ND, Chang J, Tong Y, Tiplitsky S, Lin J, Yohannes E, Tar M, Chance M, Christ GJ, Melman A, Davies KD (2011) Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways. BJU Int 107:1676\u20131684. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09655.x","journal-title":"BJU Int"},{"key":"2249_CR62","doi-asserted-by":"publisher","first-page":"797548","DOI":"10.1155\/2013\/797548","volume":"2013","author":"L-L Kong","year":"2013","unstructured":"Kong L-L, Wu H, Cui W-P, Zhou W-H, Luo P, Sun J, Yuan H, Miao L-N (2013) Advances in murine models of diabetic nephropathy. J Diabetes Res 2013:797548\u2013797548. https:\/\/doi.org\/10.1155\/2013\/797548","journal-title":"J Diabetes Res"},{"key":"2249_CR63","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF00300072","volume":"21","author":"HP Koo","year":"1993","unstructured":"Koo HP, Santarosa RP, Buttyan R, Shabisgh R, Olsson CA, Kaplan SA (1993) Early molecular changes asociated with streptozotocin-induced diabetic bladder hypertrophy in the rat. Urol Res 21:375\u2013381. https:\/\/doi.org\/10.1007\/BF00300072","journal-title":"Urol Res"},{"key":"2249_CR64","doi-asserted-by":"publisher","unstructured":"Laddha AP, Kulkarni YA (2021b) Daidzein mitigates myocardial injury in streptozotocin-induced diabetes in rats. Life Sci 265:118779. https:\/\/doi.org\/10.1016\/j.lfs.2020.118779","DOI":"10.1016\/j.lfs.2020.118779"},{"key":"2249_CR65","doi-asserted-by":"publisher","unstructured":"Laddha AP, Kulkarni YA (2022) Daidzein attenuates urinary bladder dysfunction in streptozotocin-induced diabetes in rats by NOX-4 and RAC-1 inhibition. Naunyn-Schmiedeberg's Arch Pharmacol this issue. https:\/\/doi.org\/10.1007\/s00210-022-02246-y","DOI":"10.1007\/s00210-022-02246-y"},{"key":"2249_CR66","doi-asserted-by":"publisher","first-page":"118779","DOI":"10.1016\/j.lfs.2020.118779","volume":"265","author":"AP Laddha","year":"2021","unstructured":"Laddha AP, Kulkarni YA (2021) Daidzein ameliorates diabetic retinopathy in experimental animals. Life Sci 265:118779","journal-title":"Life Sci"},{"issue":"Suppl","key":"2249_CR67","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/0006-2952(91)90400-y","volume":"42","author":"J Latifpour","year":"1991","unstructured":"Latifpour J, Gousse A, Yoshida M, Weiss RM (1991) Muscarinic receptors in diabetic rat prostate. Biochem Pharmacol 42(Suppl):S113-119. https:\/\/doi.org\/10.1016\/0006-2952(91)90400-y","journal-title":"Biochem Pharmacol"},{"key":"2249_CR68","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s0022-5347(17)37374-3","volume":"147","author":"J Latifpour","year":"1992","unstructured":"Latifpour J, Gousse A, Yoshida M, Weiss RM (1992) Effect of insulin and dietary myoinositol on muscarinic receptor alterations in diabetic rat bladder. J Urol 147:760\u2013763. https:\/\/doi.org\/10.1016\/s0022-5347(17)37374-3","journal-title":"J Urol"},{"key":"2249_CR69","doi-asserted-by":"publisher","unstructured":"Lee SJ, Karter AJ, Thai JN, Van Den Eeden SK, Huang ES (2013) Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health 22:1049\u20131055. https:\/\/doi.org\/10.1089\/jwh.2012.4093","DOI":"10.1089\/jwh.2012.4093"},{"key":"2249_CR70","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.7150\/ijms.55274","volume":"18","author":"YC Lee","year":"2021","unstructured":"Lee YC, Hsieh TJ, Tang FH, Jhan JH, Lin KL, Juan YS, Wang HS, Long CY (2021) Therapeutic effect of low intensity extracorporeal shock wave therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model. Int J Med Sci 18:1423\u20131431. https:\/\/doi.org\/10.7150\/ijms.55274","journal-title":"Int J Med Sci"},{"key":"2249_CR71","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.juro.2013.09.020","volume":"191","author":"LO Leiria","year":"2014","unstructured":"Leiria LO, Silva FH, Davel APC, Alexandre ED, Calixto MC, De Nucci G, Monica FZ, Antunes E (2014) The soluble guanylyl cyclase activator GAY 60\u20132770 ameliorates overactive bladder in obese mice. J Urol 191:539\u2013547. https:\/\/doi.org\/10.1016\/j.juro.2013.09.020","journal-title":"J Urol"},{"key":"2249_CR72","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/dme.13126","volume":"33","author":"SM Lenherr","year":"2016","unstructured":"Lenherr SM, Clemens JQ, Braffett BH, Dunn RL, Cleary PA, Kim C, Herman WH, Hotaling JM, Jacobson AM, Brown JS, Wessells H, Sarma AV (2016) Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study. Diabet Med 33:1528\u20131535. https:\/\/doi.org\/10.1111\/dme.13126","journal-title":"Diabet Med"},{"key":"2249_CR73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/jpet.113.207266","volume":"347","author":"M Levay","year":"2013","unstructured":"Levay M, Krobert KA, Wittig K, Voigt N, Bermudez M, Wolber G, Dobrev D, Levy FO, Wieland T (2013) NSC23766, a widely used inhibitor of Rac1 activation, additionally acts as a competitive antagonist at muscarinic acetylcholine receptors. J Pharmacol Exp Ther 347:69\u201379. https:\/\/doi.org\/10.1124\/jpet.113.207266","journal-title":"J Pharmacol Exp Ther"},{"key":"2249_CR74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1743-6109.2005.00068.x","volume":"2","author":"RW Lewis","year":"2005","unstructured":"Lewis RW, Sadovsky R, Eardley I, O\u2019Leary M, Seftel A, Wang WC, Shen W, Walker DJ, Wong DG, Ahuja S (2005) The efficacy of tadalafil in clinical populations. J Sex Med 2:517\u2013531. https:\/\/doi.org\/10.1111\/j.1743-6109.2005.00068.x","journal-title":"J Sex Med"},{"key":"2249_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12868-016-0272-9","volume":"17","author":"PC Li","year":"2016","unstructured":"Li PC, Liu LF, Jou MJ, Wang HK (2016) The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice. BMC Neurosci 17:37. https:\/\/doi.org\/10.1186\/s12868-016-0272-9","journal-title":"BMC Neurosci"},{"key":"2249_CR76","doi-asserted-by":"publisher","unstructured":"Li B, Yu Q, Wang R, Gratzke C, Wang X, Spek A, Herlemann A, Tamalunas A, Strittmatter F, Waidelich R, Stief CG, Hennenberg M (2020) Inhibition of female and male human detrusor smooth muscle contraction by the Rac inhibitors EHT1864 and NSC23766. Front Pharmacol 11 https:\/\/doi.org\/10.3389\/fphar.2020.00409","DOI":"10.3389\/fphar.2020.00409"},{"key":"2249_CR77","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jfma.2019.11.017","volume":"119","author":"CF Lin","year":"2020","unstructured":"Lin CF, Chueh TH, Chung CH, Chung SD, Chang TC, Chien CT (2020) Sulforaphane improves voiding function via the preserving mitochondrial function in diabetic rats. J Formos Med Assoc 119:1422\u20131430. https:\/\/doi.org\/10.1016\/j.jfma.2019.11.017","journal-title":"J Formos Med Assoc"},{"key":"2249_CR78","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/medicina57090947","volume":"57","author":"K-L Lin","year":"2021","unstructured":"Lin K-L, Chueh K-S, Lu J-H, Chuang S-M, Wu B-N, Lee Y-C, Wu Y-H, Shen M-C, Sun T-W, Long C-Y (2021) Low intensity extracorporeal shock wave therapy as a novel treatment for stress urinary incontinence: a randomized-controlled clinical study. Medicina 57:947","journal-title":"Medicina"},{"key":"2249_CR79","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3760\/cma.j.issn.0366-6999.20132407","volume":"127","author":"G Liu","year":"2014","unstructured":"Liu G, Daneshgari F (2014) Diabetic bladder dysfunction. Chin Med J 127:1357\u20131364","journal-title":"Chin Med J"},{"key":"2249_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/nau.23799","volume":"38","author":"YD Liu","year":"2019","unstructured":"Liu YD, Zhang SC, Xue J, Wei ZQ, Shen BX, Ding LC (2019) Caffeine improves bladder function in streptozotocin-induced diabetic rats. Neurourol Urodyn 38:81\u201386. https:\/\/doi.org\/10.1002\/nau.23799","journal-title":"Neurourol Urodyn"},{"key":"2249_CR81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2337\/db14-0249","volume":"64","author":"DE Livingstone","year":"2015","unstructured":"Livingstone DE, Barat P, Di Rollo EM, Rees GA, Weldin BA, Rog-Zielinska EA, MacFarlane DP, Walker BR, Andrew R (2015) 5\u03b1-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents. Diabetes 64:447\u2013458. https:\/\/doi.org\/10.2337\/db14-0249","journal-title":"Diabetes"},{"key":"2249_CR82","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0306-3623(91)90454-E","volume":"22","author":"PA Longhurst","year":"1991","unstructured":"Longhurst PA, Kauer J, Levin RM (1991) The ability of insulin treatment to reverse or prevent the changes in urinary bladder function caused by streptozotocin-induced diabetes mellitus. Gen Pharmacol 22:305\u2013311","journal-title":"Gen Pharmacol"},{"key":"2249_CR83","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/01.ju.0000093561.95283.df","volume":"171","author":"PA Longhurst","year":"2004","unstructured":"Longhurst PA, Levendusky MC, Bezuijen MWF (2004) Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction. J Urol 171:933\u2013937","journal-title":"J Urol"},{"key":"2249_CR84","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/nau.23256","volume":"36","author":"LL Lua","year":"2017","unstructured":"Lua LL, Pathak P, Dandolu V (2017) Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents. Neurourol Urodyn 36:2123\u20132131. https:\/\/doi.org\/10.1002\/nau.23256","journal-title":"Neurourol Urodyn"},{"key":"2249_CR85","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1038\/s41598-020-61106-y","volume":"10","author":"K Masuda","year":"2020","unstructured":"Masuda K, Aizawa N, Watanabe D, Okegawa T, Kume H, Igawa Y, Fukuhara H (2020) Pathophysiological changes of the lower urinary tract behind voiding dysfunction in streptozotocin-induced long-term diabetic rats. Sci Rep 10:4182. https:\/\/doi.org\/10.1038\/s41598-020-61106-y","journal-title":"Sci Rep"},{"key":"2249_CR86","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/bju.14535","volume":"123","author":"T Matsumoto","year":"2019","unstructured":"Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C (2019) Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan. BJU Int 123:877\u2013884. https:\/\/doi.org\/10.1111\/bju.14535","journal-title":"BJU Int"},{"key":"2249_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/luts.12283","volume":"12","author":"T Matsuo","year":"2020","unstructured":"Matsuo T, Miyata Y, Araki K, Mukae Y, Otsubo A, Ohba K, Sakai H (2020) Efficacy of tadalafil therapy and changes in oxidative stress levels in male patients with lower urinary tract symptoms and overactive bladder. Low Urin Tract Symptoms 12:47\u201353. https:\/\/doi.org\/10.1111\/luts.12283","journal-title":"Low Urin Tract Symptoms"},{"key":"2249_CR88","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2022) 2022 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J\u00a024:4\u2013131.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2249_CR89","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1464-410X.2009.08573.x","volume":"104","author":"A Melman","year":"2009","unstructured":"Melman A, Zotova E, Kim M, Arezzo J, Davies K, DiSanto M, Tar M (2009) Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats. BJU Int 104:1292\u20131300. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08573.x","journal-title":"BJU Int"},{"key":"2249_CR90","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0022-5347(05)67529-5","volume":"163","author":"MC Michel","year":"2000","unstructured":"Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M (2000) Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 163:1725\u20131729","journal-title":"J Urol"},{"key":"2249_CR91","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00210-015-1137-y","volume":"388","author":"MC Michel","year":"2015","unstructured":"Michel MC, Chess-Williams R, Hegde SS (2015) Are blood vessels a target to treat lower urinary tract dysfunction? Naunyn-Schmiedeberg\u2019s Arch Pharmacol 388:687\u2013694. https:\/\/doi.org\/10.1007\/s00210-015-1137-y","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2249_CR92","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00210-015-1134-1","volume":"388","author":"MC Michel","year":"2015","unstructured":"Michel MC, Mayoux E, Vallon V (2015) A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans. Naunyn Schmiedebergs Arch Pharmacol 388:801\u2013816. https:\/\/doi.org\/10.1007\/s00210-015-1134-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2249_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.019","volume":"164","author":"MC Michel","year":"2016","unstructured":"Michel MC, Brunner HR, Foster C, Huo Y (2016) Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacol Ther 164:1\u201381. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.019","journal-title":"Pharmacol Ther"},{"key":"2249_CR94","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3389\/fphar.2020.00816","volume":"11","author":"MC Michel","year":"2020","unstructured":"Michel MC, Schumacher H, Mehlburger L, de la Rosette JJMCH (2020) Factors associated with nocturia-related quality of life in men with lower urinary tract symptoms and treated with tamsulosin oral controlled absorption system in a noniInterventional study. Front Pharmacol 11:816. https:\/\/doi.org\/10.3389\/fphar.2020.00816","journal-title":"Front Pharmacol"},{"key":"2249_CR95","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1111\/bph.15648","volume":"178","author":"MC Michel","year":"2021","unstructured":"Michel MC, Yesilyurt ZE, \u00d6zt\u00fcrk G, Arioglu Inan E (2021) Empagliflozin and linagliptin do not affect urinary bladder enlargement in a rat model of type 1 diabetes. Br J Pharmacol 178:4977\u20134978. https:\/\/doi.org\/10.1111\/bph.15648","journal-title":"Br J Pharmacol"},{"key":"2249_CR96","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1007\/s12035-019-01696-5","volume":"56","author":"G Mohammad","year":"2019","unstructured":"Mohammad G, Duraisamy AJ, Kowluru A, Kowluru RA (2019) Functional regulation of an oxidative stress mediator, Rac1, in diabetic retinopathy. Mol Neurobiol 56:8643\u20138655. https:\/\/doi.org\/10.1007\/s12035-019-01696-5","journal-title":"Mol Neurobiol"},{"key":"2249_CR97","doi-asserted-by":"publisher","first-page":"15639","DOI":"10.1038\/srep15639","volume":"5","author":"HH Mosli","year":"2015","unstructured":"Mosli HH, Esmat A, Atawia RT, Shoieb SM, Mosli HA, Abdel-Naim AB (2015) Metformin attenuates testosterone-induced prostatic hyperplasia in rats: a pharmacological perspective. Sci Rep 5:15639. https:\/\/doi.org\/10.1038\/srep15639","journal-title":"Sci Rep"},{"key":"2249_CR98","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s00125-020-05222-4","volume":"63","author":"AH Mossa","year":"2020","unstructured":"Mossa AH, Galan A, Cammisotto PG, Velasquez Flores M, Shamout S, Barcelona P, Saragovi HU, Campeau L (2020) Antagonism of proNGF or its receptor p75NTR reverses remodelling and improves bladder function in a mouse model of diabetic voiding dysfunction. Diabetologia 63:1932\u20131946. https:\/\/doi.org\/10.1007\/s00125-020-05222-4","journal-title":"Diabetologia"},{"key":"2249_CR99","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/ndt\/gfi155","volume":"20","author":"JF Navarro","year":"2005","unstructured":"Navarro JF, Mora C (2005) Role of inflammation in diabetic complications. Nephrol Dial Transplant 20:2601\u20132604","journal-title":"Nephrol Dial Transplant"},{"key":"2249_CR100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00210-006-0104-z","volume":"374","author":"N Niclau\u00df","year":"2006","unstructured":"Niclau\u00df N, Michel-Reher MB, Alewijnse AE, Michel MC (2006) Comparison of three radioligands for the labelling of human \u00df-adrenoceptor subtypes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 374:99\u2013105. https:\/\/doi.org\/10.1007\/s00210-006-0104-z","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2249_CR101","doi-asserted-by":"publisher","first-page":"e102644","DOI":"10.1371\/journal.pone.0102644","volume":"9","author":"J Nirmal","year":"2014","unstructured":"Nirmal J, Tyagi P, Chuang YC, Lee WC, Yoshimura N, Huang CC, Rajaganapathy B, Chancellor MB (2014) Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PLoS ONE 9:e102644. https:\/\/doi.org\/10.1371\/journal.pone.0102644","journal-title":"PLoS ONE"},{"key":"2249_CR102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/luts.12005","volume":"5","author":"J Obata","year":"2013","unstructured":"Obata J, Matsumoto K, Yamanaka H, Ninomiya A, Nakamura S (2013) Who would benefit from solifenacin add-on therapy to tamsulosin for overactive bladder symptoms associated with nenign prostatic hyperplasia? Low Urin Tract Symptoms 5:145\u2013149. https:\/\/doi.org\/10.1111\/luts.12005","journal-title":"Low Urin Tract Symptoms"},{"key":"2249_CR103","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/nau.21022","volume":"30","author":"P Ochodnicky","year":"2011","unstructured":"Ochodnicky P, Cruz CD, Yoshimura N, Michel MC (2011) Nerve growth factor in bladder dysfunction: contributing factor, biomarker and therapeutic target. Neurourol Urodyn 30:1227\u20131241. https:\/\/doi.org\/10.1002\/nau.21022","journal-title":"Neurourol Urodyn"},{"key":"2249_CR104","doi-asserted-by":"publisher","unstructured":"Oelke M , Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N'dow J, Nordling J, de la Rosette JJ (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.004","DOI":"10.1016\/j.eururo.2013.03.004"},{"key":"2249_CR105","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1152\/ajpregu.00033.2013","volume":"306","author":"S Oger-Roussel","year":"2014","unstructured":"Oger-Roussel S, Behr-Roussel D, Caisey S, Kergoat M, Charon C, Audet A, Bernab\u00e9 J, Alexandre L, Giuliano F (2014) Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat. Am J Physiol Regul Integr Comp Physiol 306:R108-117. https:\/\/doi.org\/10.1152\/ajpregu.00033.2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2249_CR106","doi-asserted-by":"publisher","first-page":"174502","DOI":"10.1016\/j.ejphar.2021.174502","volume":"910","author":"AL Oliveira","year":"2021","unstructured":"Oliveira AL, de Oliveira MG, Medeiros ML, M\u00f3nica FZ, Antunes E (2021) Metformin abrogates the voiding dysfunction induced by prolonged methylglyoxal intake. Eur J Pharmacol 910:174502. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174502","journal-title":"Eur J Pharmacol"},{"key":"2249_CR107","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1172\/JCI131126","volume":"130","author":"AE O'Mara","year":"2020","unstructured":"O\u2019Mara AE, Johnson JW, Linderman JD, Brychta RJ, McGehee S, Fletcher LA, Fink YA, Kapuria D, Cassimatis TM, Kelsey N, Cero C, Abdul-Sater Z, Piccinini F, Baskin AS, Leitner BP, Cai H, Millo CM, Dieckmann W, Walter M, Javitt NB, Rotman Y, Walter PJ, Ader M, Bergman RN, Herscovitch P, Chen KY, Cypess AM (2020) Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Investig 130:2209\u20132219. https:\/\/doi.org\/10.1172\/JCI131126","journal-title":"J Clin Investig"},{"key":"2249_CR108","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00240-002-0247-4","volume":"30","author":"B \u00d6zt\u00fcrk","year":"2002","unstructured":"\u00d6zt\u00fcrk B, Centinkaya M, G\u00fcr S, Ugurlu \u00d6, \u00d6ztekin V, Aki FT (2002) The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder. Urol Res 30:178\u2013184. https:\/\/doi.org\/10.1007\/s00240-002-0247-4","journal-title":"Urol Res"},{"key":"2249_CR109","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2013.04.047","volume":"712","author":"M-H Park","year":"2013","unstructured":"Park M-H, Ju J-W (2013) Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice. Eur J Pharmacol 712:48\u201352","journal-title":"Eur J Pharmacol"},{"key":"2249_CR110","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.lfs.2006.03.022","volume":"79","author":"SA Park","year":"2006","unstructured":"Park SA, Choi M-S, Cho S-Y, Seo J-S, Jung UJ, Kim M-J, Sung M-K, Park YB, Lee M-K (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL\/KsJ-db\/db mice. Life Sci 79:1207\u20131213","journal-title":"Life Sci"},{"key":"2249_CR111","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biochi.2004.07.008","volume":"86","author":"DP Poladia","year":"2004","unstructured":"Poladia DP, Bauer JA (2004) Oxidant driven signaling pathways during diabetes: role of Rac1 and modulation of protein kinase activity in mouse urinary bladder. Biochimie 86:543\u2013551. https:\/\/doi.org\/10.1016\/j.biochi.2004.07.008","journal-title":"Biochimie"},{"key":"2249_CR112","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1113\/jphysiol.2013.262998","volume":"592","author":"A Rahman","year":"2014","unstructured":"Rahman A, Davis B, L\u00f6vdahl C, Hanumaiah VT, Feil R, Brakebusch C, Arner A (2014) The small GTPase Rac1 is required for smooth muscle contraction. J Physiol 592:915\u2013926. https:\/\/doi.org\/10.1113\/jphysiol.2013.262998","journal-title":"J Physiol"},{"key":"2249_CR113","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrurol.2013.101","volume":"10","author":"MS Rahnama'i","year":"2013","unstructured":"Rahnama\u2019i MS, \u00dcckert S, Hohnen R, van Koeveringe GA (2013) The role of phosphodiesterases in bladder pathophysiology. Nat Rev Urol 10:414\u2013424. https:\/\/doi.org\/10.1038\/nrurol.2013.101","journal-title":"Nat Rev Urol"},{"key":"2249_CR114","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1038\/sj.bjp.0706504","volume":"147","author":"AG Ramage","year":"2006","unstructured":"Ramage AG (2006) The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol 147:S120\u2013S131","journal-title":"Br J Pharmacol"},{"key":"2249_CR115","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ptr.4970","volume":"28","author":"EL Robb","year":"2014","unstructured":"Robb EL, Stuart JA (2014) Multiple phytoestrogens inhibit cell growth and confer cytoprotection by inducing manganese superoxide dismutase expression. Phytother Res 28:120\u2013131","journal-title":"Phytother Res"},{"key":"2249_CR116","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ptr.4699","volume":"27","author":"M Roghani","year":"2013","unstructured":"Roghani M, Vaez Mahdavi MR, Jalali-Nadoushan MR, Baluchnejadmojarad T, Naderi G, Roghani-Dehkordi F, Taghi Joghataei M, Kord M (2013) Chronic administration of daidzein, a soybean isoflavone, improves endothelial dysfunction and attenuates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 27:112\u2013117","journal-title":"Phytother Res"},{"key":"2249_CR117","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/s0006-2952(96)00565-5","volume":"52","author":"M Saito","year":"1996","unstructured":"Saito M, Nishi K, Fukumoto Y, Weiss RM, Latifpour J (1996) Characterization of endothelin receptors in streptozotocin-induced diabetic rat vas deferens. Biochem Pharmacol 52:1593\u20131598. https:\/\/doi.org\/10.1016\/s0006-2952(96)00565-5","journal-title":"Biochem Pharmacol"},{"key":"2249_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/a:1007041909477","volume":"210","author":"M Saito","year":"2000","unstructured":"Saito M, Wada Y, Ikeda K, Wang Z, Foster HE Jr, Smith SD, Weiss RM, Latifpour J (2000) Expression of endothelin receptor subtypes and their messenger RNAs in diabetic rat prostate: effect of insulin treatment. Mol Cell Biochem 210:1\u201312. https:\/\/doi.org\/10.1023\/a:1007041909477","journal-title":"Mol Cell Biochem"},{"key":"2249_CR119","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0014-2999(99)00753-0","volume":"387","author":"M Saito","year":"2000","unstructured":"Saito M, Wada Y, Ikeda K, Wang Z, Smith SD, Foster HE, Nishi K, Weiss RM, Latifpour J (2000) Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome. Eur J Pharmacol 387:253\u2013263. https:\/\/doi.org\/10.1016\/s0014-2999(99)00753-0","journal-title":"Eur J Pharmacol"},{"key":"2249_CR120","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0022-5347(05)64636-8","volume":"168","author":"K Sasaki","year":"2002","unstructured":"Sasaki K, Chancellor MB, Phelan MW, Yokoyama T, Fraser MO, Seki S, Kubo K, Kumon H, De Groat WC, Yoshimura N (2002) Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J Urol 168:1259\u20131264. https:\/\/doi.org\/10.1016\/S0022-5347(05)64636-8","journal-title":"J Urol"},{"key":"2249_CR121","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2337\/diabetes.53.10.2723","volume":"53","author":"K Sasaki","year":"2004","unstructured":"Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, De Groat WC, Yoshimura N (2004) Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53:2723\u20132730","journal-title":"Diabetes"},{"key":"2249_CR122","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/ijcp.12196","volume":"67","author":"T Schneider","year":"2013","unstructured":"Schneider T, Marschall-Kehrel D, Hanisch JU, Michel MC (2013) Does concomitant diabetes affect treatment responses in overactive bladder patients? Int J Clin Pract 67:1138\u20131143. https:\/\/doi.org\/10.1111\/ijcp.12196","journal-title":"Int J Clin Pract"},{"key":"2249_CR123","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/luts.12317","volume":"12","author":"N Sekido","year":"2020","unstructured":"Sekido N, Otsuki T, Kida J, Mashimo H, Wakamatsu D, Okada H, Matsuya H (2020) EP2 and EP3 receptors as therapeutic targets for underactive bladder\/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model. Low Urin Tract Symptoms 12:285\u2013291. https:\/\/doi.org\/10.1111\/luts.12317","journal-title":"Low Urin Tract Symptoms"},{"key":"2249_CR124","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/pds.5090","volume":"29","author":"DJ Selig","year":"2020","unstructured":"Selig DJ, Brown AJ, DeLuca JP, Kress AT, Livezey JR, Oliver TG, Por ED, Thelus Jean R (2020) Risk of type 2 diabetes mellitus by antimuscarinic agents among adult females receiving care in the military health system. Pharmacoepidemiol Drug Saf 29:1605\u20131615. https:\/\/doi.org\/10.1002\/pds.5090","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2249_CR125","doi-asserted-by":"publisher","unstructured":"Shin JH, Ryu CM, Ju H, Yu HY, Song S, Hong KS, Chung HM, Park J, Shin DM, Choo MS (2020) Therapeutic efficacy of human embryonic stem cell-derived multipotent stem\/stromal cells in diabetic detrusor underactivity: a preclinical study. J Clin Med 92853.\u00a0https:\/\/doi.org\/10.3390\/jcm9092853","DOI":"10.3390\/jcm9092853"},{"key":"2249_CR126","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0006-8993(97)01287-0","volume":"782","author":"BC Steinbacher Jr","year":"1998","unstructured":"Steinbacher BC Jr, Nadelhaft I (1998) Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat. Brain Res 782:255\u2013260. https:\/\/doi.org\/10.1016\/S0006-8993(97)01287-0","journal-title":"Brain Res"},{"key":"2249_CR127","first-page":"230","volume":"6","author":"S-J Su","year":"2000","unstructured":"Su S-J, Yeh T-M, Lei H-Y, Chow N-H (2000) The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6:230\u2013236","journal-title":"Clin Cancer Res"},{"key":"2249_CR128","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.2337\/db16-0480","volume":"65","author":"T Szasz","year":"2016","unstructured":"Szasz T, Wenceslau CF, Burgess B, Nunes KP, Webb RC (2016) Toll-like receptor 4 activation contributes to diabetic bladder dysfunction in a murine model of type 1 diabetes. Diabetes 65:3754\u20133764. https:\/\/doi.org\/10.2337\/db16-0480","journal-title":"Diabetes"},{"key":"2249_CR129","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000398811","volume":"95","author":"S Tatemichi","year":"2015","unstructured":"Tatemichi S, Tsuchioka K, Yonekubo S, Maruyama K, Kobayashi M (2015) Effects of Silodosin, an \u03b11A-adrenoceptor antagonist, and distigmine, an acetylcholinesterase inhibitor, and their combined effects on impaired voiding function in Zucker Diabetic Fatty rats. Pharmacology 95:285\u2013292. https:\/\/doi.org\/10.1159\/000398811","journal-title":"Pharmacology"},{"key":"2249_CR130","doi-asserted-by":"publisher","first-page":"F738","DOI":"10.1152\/ajprenal.00333.2015","volume":"310","author":"P Thurmond","year":"2016","unstructured":"Thurmond P, Yang JH, Azadzoi KM (2016) LUTS in pelvic ischemia: a new concept in voiding dysfunction. Am J Physiol 310:F738\u2013F743. https:\/\/doi.org\/10.1152\/ajprenal.00333.2015","journal-title":"Am J Physiol"},{"key":"2249_CR131","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/j.1464-410X.2005.05854.x","volume":"96","author":"YC Tong","year":"2005","unstructured":"Tong YC, Cheng JT (2005) Changes in bladder nerve-growth factor and p75 NTR genetic expression in streptozotocin-induced diabetic rats. BJU Int 96:1392\u20131396. https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05854.x","journal-title":"BJU Int"},{"key":"2249_CR132","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/01.ju.0000146268.45662.36","volume":"173","author":"K Torimoto","year":"2005","unstructured":"Torimoto K, Hirao Y, Matsuyoshi H, de Groat WC, Chancellor MB, Yoshimura N (2005) alpha1-Adrenergic mechanism in diabetic urethral dysfunction in rats. J Urol 173:1027\u20131032. https:\/\/doi.org\/10.1097\/01.ju.0000146268.45662.36","journal-title":"J Urol"},{"key":"2249_CR133","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.21873\/invivo.11674","volume":"33","author":"P Tsounapi","year":"2019","unstructured":"Tsounapi P, Honda M, Hikita K, Sofikitis N, Takenaka A (2019) Oxidative stress alterations in the bladder of a short-period type 2 diabetes rat model: antioxidant treatment can be beneficial for the bladder. In Vivo 33:1819\u20131826. https:\/\/doi.org\/10.21873\/invivo.11674","journal-title":"In Vivo"},{"key":"2249_CR134","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/bju.12684","volume":"116","author":"H Tu","year":"2015","unstructured":"Tu H, Cao N, Gu B, Si J, Chen Z, Andersson KE (2015) Serotonin (5-HT)2A\/2C receptor agonist (2,5-dimethoxy-4-idophenyl)-2-aminopropane hydrochloride (DOI) improves voiding efficiency in the diabetic rat. BJU Int 116:147\u2013155. https:\/\/doi.org\/10.1111\/bju.12684","journal-title":"BJU Int"},{"key":"2249_CR135","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.phrs.2012.06.007","volume":"66","author":"A Valeri","year":"2012","unstructured":"Valeri A, Fiorenzani P, Rossi R, Aloisi AM, Valoti M, Pessina F (2012) The soy phytoestrogens genistein and daidzein as neuroprotective agents against anoxia-glucopenia and reperfusion damage in rat urinary bladder. Pharmacol Res 66:309\u2013316","journal-title":"Pharmacol Res"},{"key":"2249_CR136","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2337\/dc07-2375","volume":"32","author":"SK Van Den Eeden","year":"2009","unstructured":"Van Den Eeden SK, Sarma AV, Rutledge BN, Cleary PA, Kusek JW, Nyberg LM, McVary KT, Wessells H (2009) Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study. Diabetes Care 32:664\u2013670. https:\/\/doi.org\/10.2337\/dc07-2375","journal-title":"Diabetes Care"},{"key":"2249_CR137","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1046\/j.1464-410x.2000.00597.x","volume":"85","author":"Z Wang","year":"2000","unstructured":"Wang Z, Ikeda K, Wada Y, Foster HE, Weiss RM, Latifpour J (2000) Expression and localization of basic fibroblast growth factor in diabetic rat prostate. BJU Int 85:945\u2013952. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00597.x","journal-title":"BJU Int"},{"key":"2249_CR138","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jdiacomp.2009.06.002","volume":"24","author":"XM Wang","year":"2010","unstructured":"Wang XM, Zhang MX, Zhao L, Han B, Xu P, Xue M (2010) The Starling mechanism of the urinary bladder contractile function and the influence of hyperglycemia on diabetic rats. J Diabetes Complicat 24:121\u2013128. https:\/\/doi.org\/10.1016\/j.jdiacomp.2009.06.002","journal-title":"J Diabetes Complicat"},{"key":"2249_CR139","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.2337\/db11-1763","volume":"61","author":"Z Wang","year":"2012","unstructured":"Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF, Olumi AF (2012) Inhibition of TNF-\u03b1 improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61:2134\u20132145. https:\/\/doi.org\/10.2337\/db11-1763","journal-title":"Diabetes"},{"key":"2249_CR140","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/bph.13099","volume":"172","author":"Y Wang","year":"2015","unstructured":"Wang Y, Kunit T, Ciotkowska A, Rutz B, Schreiber A, Strittmatter F, Waidelich R, Liu C, Stief CG, Gratzke C, Hennenberg M (2015) Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864. Br J Pharmacol 172:2905\u20132917. https:\/\/doi.org\/10.1111\/bph.13099","journal-title":"Br J Pharmacol"},{"key":"2249_CR141","doi-asserted-by":"publisher","first-page":"E471","DOI":"10.1152\/ajpendo.00134.2016","volume":"311","author":"Y Wang","year":"2016","unstructured":"Wang Y, Deng GG, Davies KP (2016) Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer. Am J Physiol-Endocrinol Metab 311:E471\u2013E479. https:\/\/doi.org\/10.1152\/ajpendo.00134.2016","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"2249_CR142","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bju.14216","volume":"122","author":"HS Wang","year":"2018","unstructured":"Wang HS, Oh BS, Wang B, Ruan Y, Zhou J, Banie L, Lee YC, Tamaddon A, Zhou T, Wang G, Lin G, Lue TF (2018) Low-intensity extracorporeal shockwave therapy ameliorates diabetic underactive bladder in streptozotocin-induced diabetic rats. BJU Int 122:490\u2013500. https:\/\/doi.org\/10.1111\/bju.14216","journal-title":"BJU Int"},{"key":"2249_CR143","doi-asserted-by":"publisher","first-page":"118468","DOI":"10.1016\/j.lfs.2020.118468","volume":"261","author":"R Wang","year":"2020","unstructured":"Wang R, Yu Q, Wang X, Li B, Ciotkowska A, Rutz B, Wang Y, Stief CG, Hennenberg M (2020) Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells. Life Sci 261:118468. https:\/\/doi.org\/10.1016\/j.lfs.2020.118468","journal-title":"Life Sci"},{"key":"2249_CR144","doi-asserted-by":"publisher","first-page":"608637","DOI":"10.3389\/fphar.2021.608637","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Dai L, Yue X, Shen C, Li T, Long L, Zhi Y, Wang Y, Shen G, Shi C, Liu Y, Fang Q, Li W (2021) IR-61 improves voiding function via mitochondrial protection in diabetic tats. Front Pharmacol 12:608637. https:\/\/doi.org\/10.3389\/fphar.2021.608637","journal-title":"Front Pharmacol"},{"key":"2249_CR145","doi-asserted-by":"publisher","unstructured":"Wang CC, Jiang YH, Kuo HC (2020a) The pharmacological mechanism of diabetes mellitus-associated overactive bladder and Its treatment with botulinum toxin A. Toxins (Basel)\u00a012(3):186.\u00a0https:\/\/doi.org\/10.3390\/toxins12030186","DOI":"10.3390\/toxins12030186"},{"key":"2249_CR146","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1681\/asn.2018010103","volume":"29","author":"C Wanner","year":"2018","unstructured":"Wanner C, Heerspink HJL, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, Hantel S, Woerle H-J, Broedl UC, von Eynatten M, Groop P-H (2018) Empagliflozin and kidney function decline in patients with type 2 diabetes: a Slope analysis from the EMPA-REG OUTCOME trial. J Am Soc Nephrol 29:2755\u20132769. https:\/\/doi.org\/10.1681\/asn.2018010103","journal-title":"J Am Soc Nephrol"},{"key":"2249_CR147","doi-asserted-by":"publisher","first-page":"l1204","DOI":"10.1136\/bmj.l1204","volume":"365","author":"L Wei","year":"2019","unstructured":"Wei L, Lai EC, Kao-Yang YH, Walker BR, MacDonald TM, Andrew R (2019) Incidence of type 2 diabetes mellitus in men receiving steroid 5\u03b1-reductase inhibitors: population based cohort study. BMJ 365:l1204. https:\/\/doi.org\/10.1136\/bmj.l1204","journal-title":"BMJ"},{"key":"2249_CR148","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s11064-017-2401-y","volume":"42","author":"W WenBo","year":"2017","unstructured":"WenBo W, Fei Z, YiHeng D, Wei W, TingMang Y, WenHao Z, QianRu L, HaiTao L (2017) Human umbilical cord mesenchymal stem cells overexpressing nerve growth factor ameliorate diabetic cystopathy in rats. Neurochem Res 42:3537\u20133547. https:\/\/doi.org\/10.1007\/s11064-017-2401-y","journal-title":"Neurochem Res"},{"key":"2249_CR149","first-page":"300","volume":"17","author":"W Whitmire","year":"2011","unstructured":"Whitmire W, Al-Gayyar MMH, Abdelsaid M, Yousufzai BK, El-Remessy AB (2011) Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol vis 17:300\u2013308","journal-title":"Mol vis"},{"key":"2249_CR150","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eururo.2007.12.007","volume":"54","author":"LPW Witte","year":"2008","unstructured":"Witte LPW, Chapple CR, de la Rosette JJMCH, Michel MC (2008) Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol 54:326\u2013334. https:\/\/doi.org\/10.1016\/j.eururo.2007.12.007","journal-title":"Eur Urol"},{"key":"2249_CR151","unstructured":"World Health Organization (2016) Diabetes Fact Sheet."},{"key":"2249_CR152","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.juro.2012.08.222","volume":"189","author":"N Xiao","year":"2013","unstructured":"Xiao N, Wang Z, Huang Y, Daneshgari F, Liu G (2013) Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes. J Urol 189:1130\u20131136. https:\/\/doi.org\/10.1016\/j.juro.2012.08.222","journal-title":"J Urol"},{"key":"2249_CR153","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/iju.12695","volume":"22","author":"N Xiao","year":"2015","unstructured":"Xiao N, Huang Y, Kavran M, Elrashidy RA, Liu G (2015) Short-term diabetes- and diuresis-induced alterations of the bladder are mostly reversible in rats. Int J Urol 22:410\u2013415. https:\/\/doi.org\/10.1111\/iju.12695","journal-title":"Int J Urol"},{"key":"2249_CR154","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2009.04.021","volume":"47","author":"S-Z Xu","year":"2009","unstructured":"Xu S-Z, Zhong W, Ghavideldarestani M, Saurabh R, Lindow SW, Atkin SL (2009) Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury. Free Radical Biol Med 47:167\u2013175","journal-title":"Free Radical Biol Med"},{"key":"2249_CR155","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3892\/etm.2021.9932","volume":"21","author":"J Xue","year":"2021","unstructured":"Xue J, Liu Y, Zhang S, Ding L, Shen B, Shao Y, Wei Z (2021) Caffeine improves bladder function in diabetic rats via a neuroprotective effect. Exp Ther Med 21:501. https:\/\/doi.org\/10.3892\/etm.2021.9932","journal-title":"Exp Ther Med"},{"key":"2249_CR156","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.eururo.2008.03.015","volume":"55","author":"S Yamada","year":"2009","unstructured":"Yamada S, Takeuchi C, Oyunzul L, Ito Y (2009) Bladder angiotensin-II receptors: characterization and alteration in bladder outlet obstruction. Eur Urol 55:482\u2013490. https:\/\/doi.org\/10.1016\/j.eururo.2008.03.015","journal-title":"Eur Urol"},{"key":"2249_CR157","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fphar.2019.00911","volume":"10","author":"ZE Yesilyurt","year":"2019","unstructured":"Yesilyurt ZE, Erdogan BR, Karaomerlioglu I, M\u00fcderrisoglu AE, Michel MC, Arioglu Inan E (2019) Urinary bladder weight and function in a rat model of mild hyperglycemia and its treatment with dapagliflozin. Front Pharmacol 10:911. https:\/\/doi.org\/10.3389\/fphar.2019.00911","journal-title":"Front Pharmacol"},{"issue":"Suppl 2","key":"2249_CR158","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1002\/nau.24746","volume":"42","author":"ZE Yesilyurt","year":"2021","unstructured":"Yesilyurt ZE, Ert\u00fcrk BM, Erdogan BR, Arioglu Inan E, Michel MC (2021) Effects of the sodium-glucose transporter 2 inhibitor empagliflozin on bladder sie, contraction and ralexation in a rat model of type 1 diabetes. Neurourol Urodyn 42(Suppl 2):S141\u2013S142. https:\/\/doi.org\/10.1002\/nau.24746","journal-title":"Neurourol Urodyn"},{"key":"2249_CR159","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1745-7254.2006.00333.x","volume":"27","author":"C-r Yi","year":"2006","unstructured":"Yi C-r, Wei Z-q, Deng X-l, Sun Z-y, Li X-r, Tian C-g (2006) Effects of coffee and caffeine on bladder dysfunction in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 27:1037\u20131043","journal-title":"Acta Pharmacol Sin"},{"key":"2249_CR160","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12894-017-0256-9","volume":"17","author":"S Yonekubo","year":"2017","unstructured":"Yonekubo S, Tatemichi S, Maruyama K, Kobayashi M (2017) Alpha1A-adrenoceptor antagonist improves underactive bladder associated with diabetic cystopathy via bladder blood flow in rats. BMC Urol 17:64. https:\/\/doi.org\/10.1186\/s12894-017-0256-9","journal-title":"BMC Urol"},{"key":"2249_CR161","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00210-005-0010-9","volume":"372","author":"M Yono","year":"2005","unstructured":"Yono M, Pouresmail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J (2005) Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 372:251\u2013255. https:\/\/doi.org\/10.1007\/s00210-005-0010-9","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2249_CR162","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.lfs.2008.06.006","volume":"83","author":"M Yono","year":"2008","unstructured":"Yono M, Mane SM, Lin A, Weiss RM, Latifpour J (2008) Differential effects of diabetes induced by streptozotocin and that develops spontaneously on prostate growth in Bio Breeding (BB) rats. Life Sci 83:192\u2013197. https:\/\/doi.org\/10.1016\/j.lfs.2008.06.006","journal-title":"Life Sci"},{"key":"2249_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:1\u201322","journal-title":"Stem Cell Res Ther"},{"key":"2249_CR164","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/scd.2011.0244","volume":"21","author":"H Zhang","year":"2012","unstructured":"Zhang H, Qiu X, Shindel AW, Ning H, Ferretti L, Jin X, Lin G, Lin CS, Lue TF (2012) Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev 21:1391\u20131400. https:\/\/doi.org\/10.1089\/scd.2011.0244","journal-title":"Stem Cells Dev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02249-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:16:59Z","timestamp":1727183819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":164,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02249-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BRE, EAI, and GL do not report a conflict of interest. In the field of LUT dysfunction, MCM has been a consultant and\/or speaker for Apogepha, Astellas, Dr. Willmar Schwabe, GSK and Sanofi-Aventis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}